Literature DB >> 9924360

Evidence that upregulation of serum IGF-1 concentration can trigger acceleration of diabetic retinopathy.

E Chantelau1.   

Abstract

BACKGROUND: Acute reduction of chronic hyperglycaemia can accelerate early diabetic retinopathy. In adolescent patients with Mauriac's syndrome, this phenomenon is related to an upregulation of subnormal serum IGF-1 levels. AIM: To obtain longitudinal data on serum IGF-1 and retinopathy status in poorly controlled adult insulin dependent (type 1) diabetic patients without Mauriac's syndrome, in whom hyperglycaemia is reduced by intensive insulin therapy.
METHODS: Four patients with chronic severe insulin deficiency and early micro-angiopathy were studied prospectively. Changes in plasma glucose, HbA1c, serum IGF-1 levels, proteinuria, retinopathy, and clinical status were followed up closely.
RESULTS: Reducing hyperglycaemia from > 16 mmol/l (equivalent to HbA1c > 11%) to < 10 mmol/l (HbA1c < 8%) within 5 months increased serum IGF-1 levels by 70-220%. While proteinuria and symptomatic neuropathy regressed, retinopathy progressed from the mild to the severe non-proliferative stage with maculopathy (n = 4), and to the proliferative stage (n = 1). Laser coagulation was commenced upon the appearance of sight threatening macular oedema (n = 4).
CONCLUSION: Upregulation of serum IGF-1 preceding retinal deterioration in these patients suggests a cause-effect relation, consistent with earlier experimental and clinical data.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9924360      PMCID: PMC1722687          DOI: 10.1136/bjo.82.7.725

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  32 in total

1.  Insulin-like growth factors in vitreous. Studies in control and diabetic subjects with neovascularization.

Authors:  M Grant; B Russell; C Fitzgerald; T J Merimee
Journal:  Diabetes       Date:  1986-04       Impact factor: 9.461

2.  Is insulinlike growth factor I associated with diabetic retinopathy?

Authors:  D G Dills; S E Moss; R Klein; B E Klein; M Davis
Journal:  Diabetes       Date:  1990-02       Impact factor: 9.461

3.  Nutrition and somatomedin. XVII. Circulating somatomedin C during treatment of diabetic ketoacidosis.

Authors:  E W Glaser; S Goldstein; L S Phillips
Journal:  Diabetes       Date:  1987-10       Impact factor: 9.461

4.  Is menarche associated with diabetic retinopathy?

Authors:  B E Klein; S E Moss; R Klein
Journal:  Diabetes Care       Date:  1990-10       Impact factor: 19.112

5.  Irreversible progression of severe retinopathy in young type I insulin-dependent diabetes mellitus patients after improved metabolic control.

Authors:  C D Agardh; B Eckert; E Agardh
Journal:  J Diabetes Complications       Date:  1992 Apr-Jun       Impact factor: 2.852

Review 6.  Rapid onset of severe retinopathy, cataracts and neuropathy in young patients with diabetes mellitus.

Authors:  P B Carroll; R D Herskowitz; A D Goodman; R S Busch; R S Beaser
Journal:  Acta Paediatr       Date:  1992-04       Impact factor: 2.299

7.  Effect of puberty on insulinlike growth factor I and HbA1 in type I diabetes.

Authors:  D G Rogers; L D Sherman; K H Gabbay
Journal:  Diabetes Care       Date:  1991-11       Impact factor: 19.112

8.  Progression of diabetic retinopathy and changes in serum insulin-like growth factor I (IGF I) during continuous subcutaneous insulin infusion (CSII).

Authors:  S L Hyer; P S Sharp; M Sleightholm; J M Burrin; E M Kohner
Journal:  Horm Metab Res       Date:  1989-01       Impact factor: 2.936

9.  Transient proliferative diabetic retinopathy during intensified insulin treatment.

Authors:  E F Rosenlund; K Haakens; O Brinchmann-Hansen; K Dahl-Jørgensen; K F Hanssen
Journal:  Am J Ophthalmol       Date:  1988-06-15       Impact factor: 5.258

10.  Long-term follow-up of patients who underwent yttrium-90 pituitary implantation for treatment of proliferative diabetic retinopathy.

Authors:  P S Sharp; T J Fallon; O J Brazier; L Sandler; G F Joplin; E M Kohner
Journal:  Diabetologia       Date:  1987-04       Impact factor: 10.122

View more
  17 in total

1.  Treatment-induced diabetic neuropathy: a reversible painful autonomic neuropathy.

Authors:  Christopher H Gibbons; Roy Freeman
Journal:  Ann Neurol       Date:  2010-04       Impact factor: 10.422

2.  The shape of the metabolic memory of HbA1c: re-analysing the DCCT with respect to time-dependent effects.

Authors:  M Lind; A Odén; M Fahlén; B Eliasson
Journal:  Diabetologia       Date:  2010-03-18       Impact factor: 10.122

Review 3.  Ocular complications of diabetes mellitus.

Authors:  Nihat Sayin; Necip Kara; Gökhan Pekel
Journal:  World J Diabetes       Date:  2015-02-15

4.  Inhibition of EGF signaling protects the diabetic retina from insulin-induced vascular leakage.

Authors:  Masahiko Sugimoto; Alecia Cutler; Bailey Shen; Scot E Moss; Sudha K Iyengar; Ronald Klein; Judah Folkman; Bela Anand-Apte
Journal:  Am J Pathol       Date:  2013-07-03       Impact factor: 4.307

5.  Retinal neovascularization during treatment with IGF-1 for insulin resistance syndrome.

Authors:  Hirokuni Kitamei; Masahiko Yokoi; Manabu Kase; Shigeaki Ohno
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-01-26       Impact factor: 3.117

6.  Bone Marrow Fat Changes After Gastric Bypass Surgery Are Associated With Loss of Bone Mass.

Authors:  Tiffany Y Kim; Ann V Schwartz; Xiaojuan Li; Kaipin Xu; Dennis M Black; Dimitry M Petrenko; Lygia Stewart; Stanley J Rogers; Andrew M Posselt; Jonathan T Carter; Dolores M Shoback; Anne L Schafer
Journal:  J Bone Miner Res       Date:  2017-08-09       Impact factor: 6.741

7.  HbA1c variability is associated with an increased risk of retinopathy requiring laser treatment in type 1 diabetes.

Authors:  K Hietala; J Wadén; C Forsblom; V Harjutsalo; J Kytö; P Summanen; P-H Groop
Journal:  Diabetologia       Date:  2013-01-13       Impact factor: 10.122

8.  Insulin glargine reduces carotid intimal hyperplasia after balloon catheter injury in Zucker fatty rats possibly by reduction in oxidative stress.

Authors:  Subramanyam N Murthy; Sergiy Sukhanov; Jennifer McGee; Joel A Greco; Surabhi Chandra; Patrice Delafontaine; Philip J Kadowitz; Dennis B McNamara; Vivian A Fonseca
Journal:  Mol Cell Biochem       Date:  2009-04-10       Impact factor: 3.396

9.  Prevention of diabetic eye disease: the commonest cause of blindness in individuals younger than 65 years.

Authors:  Patrizio Tatti; Patrizia Di Mauro; Leonardo Masselli; Adriano Longobardi; Annabel Barber
Journal:  Clin Ophthalmol       Date:  2010-11-15

10.  A1C variability predicts incident cardiovascular events, microalbuminuria, and overt diabetic nephropathy in patients with type 1 diabetes.

Authors:  Johan Wadén; Carol Forsblom; Lena M Thorn; Daniel Gordin; Markku Saraheimo; Per-Henrik Groop
Journal:  Diabetes       Date:  2009-08-03       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.